Introduction
Left ventricular opacification [uciano.asati@uniromal .it Improved endocardia[ border delineation may be achieved after [eft ventricu[ar cavity opacification (LVO) fo[[owin~ intravenous injection of contrast. LVO and myocardial perfusion can be obtained durin~ the same session usin~ the same contrast a~ent and the same equipment 1,2.
In recent years several studies have shown the incremental diagnostic value of ultrasound contrast media for LVO and its impact on the clinical decision makin~ 3,4. LVO may provide improved information on LV function in those patients in whom ima~in~ is suboptimal and non-diagnostic. Further, LVO may improve quantification of [eft ventricu[ar function in approximately 50% of patients, by providing better imaging in those patients in whom 2 to 6 adjacent myocardial segments (13-38%) are not adequately visualized using standard echocardiography. LVO may also improve interobserver agreement and reproducibility allowing for a more accurate evaluation of LV volumes when compared to other reference methods, such as Application of contrast may also be considered when the following clinical scenarios are suspected: (1) apical cardiomyopathy; (2) the presence of an apical thrombus, tumor or pseudoaneurysm ( fig. 1 ) or (3) left ventricular non compaction.
Research developments for LVO application
Recently new quantitative software applications for LVO have been developed, which can further improve the diagnostic capability of the contrast echo. These are aimed to (1) increase the quality of endocardial border delineation; (2) assess 3D perfusion and regional/global LV function; (3) evaluate 3D intra-cardiac flow dynamics. A very useful tool has been developed in Dr. Tonti's laboratory: starting from low frame rate (20FR are normally used with contrast) it rebuilds a loop of a single beat at a higher frame rate, almost double that of the original, providing a dear image of endocardial borders. Using dedicated software (Diogenes software) it is possible to combine improved endocardial delineation with additional information on myocardial perfusion with just one set of acquired images ( fig. 2) .
3D echocardiography is a promising new development but image quality remains inferior to 2D imaging. With 3D image reconstruction, often a number of image frame are eliminated. With the addition of contrast, the endocardial border definition is improved and thus ejection fraction may be better assessed 8 ( fig. 3, overleaf) . A further new area is assessing LV flow dynamics in 3 dimensions. In Dr Tonti's laboratory, a new software application is currently under development based on mathematical models which, by reducing the contrast infusion rate, allows for the assessment of the intra-ventricular flow dynamics of microbubbles. This has the potential for obtaining detailed information on ventricular contraction, and potential areas of thrombus formation.
Myocardial perfusion
The role of myocardial contrast echocardiography (MCE) in clinical decision-making has recently been emphasized 9-18.
A very large study on more than 1000 patients has shown the additional value of MCE in patients presenting in the emergency department with chest pain and no ST-segment elevation 19. In these patients, the assessment of regional function and myocardial perfusion added a significative prognostic value to routine echocardiography. The study demonstrated that in acute coronary syndrome when abnormal regional function and perfusion are present in the same patient the survival rate is greatly reduced.
In the setting of detecting CAD, several studies have shown the additional value of MCE over wail motion abnormalities alone during stress echocardiography. In particular, a recent large study showed a close correlation between perfusion, wail motion and survival rate. If both perfusion and wail motion are abnormal the survival rate is dramatically reduced 20.
A[[ these studies 9-2° clearly underline the incremental value of MCE in providing complementary information over and above other more established methods, such as nuclear imaging, both in chronic and acute CAD patients.
Clinical applications of parametric imaging (Qcontrast ®) using SonoVueOur experience From parametric image reconstruction, the area of contrast defect may be calculated using a four-color map segmentation; the blue area, corresponding to the largest clearly demarcated contrast defect, may be traced manually ( fig. 4) . Contrast defect area (CDA%) is expressed as a percentage of the total LV area.
Methodology
From native MCE images, the length of endocardia[ border corresponding to the segment with contrast defect (CDL) may be measured in the 2, 3-and 4-chamber views. The sum of both endocardia[ border lengths defined the size of the perfusion defect. The following formula is used to assess the relative CDL%: Total residual CDL after reperfusion x 100. Total length of endocardia[ border This software was first tested using different US equipments on 5 pigs given sulphur hexafluoride bubbles (1 m[/min) and fluorescent microspheres (reference) after the induction of 50% and 100% stenosis of [eft anterior descending coronary artery 22. A dose correlation was found between the ratio risk area/control area by microspheres and the equivalent ratio risk area/ control area (S1×13) by MCE, being approximately 0.9 for any contrast moda[ity tested 22.
Study design
Parametric MCE and SPECT were compared in 12 patients with recent myocardial infarction, including 119 segments 22. Agreement amounted to 83% (kappa: 0.53 for peak SI and 0.55 for S1×13). The sensitivity and specificity of peak SI to detect abnorma[ segmenta[ tracer uptake were 67% and 88%; the va[ues for S1×13 were 70% and 87%. Q-contrast software has then been tested in a 
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Quantitative analysis was performed on MCE images after coronary reflow and at pre-discharge using Q-contrast ® software (Bracco Imaging), as previously described zl,zz.
Resu! ts
From January 2003 until May 2004, 120 patients were enrolled. Mean age of the patient population was 59±10 years. Significant ST-segment reduction was present in 66% of patients. Infarct area was in the LAD territory in the majority of patients (87%). Sixty-two percent of them underwent primary PCI, but only 19% had a completely normal myocardial reflow after reperfusion. Two parameters described the extent of myocardial disease: the contrast defect area and the contrast defect length. The analysis of the echocardiographic characteristics of our patients population showed that mean contrast defect area and contrast defect length are lower than the extent of wail motion abnormalities; suggesting that soon after reperfusion, a portion of infarct area is normally perfused.
To evaluate the success of coronary reperfusion, microvascu[ar perfusion was assessed vs ST-segment changes and coronary artery reflow. After dividing our population according to % ST-segment reduction ( fig. 5 ), the extent of regional wail motion abnormalities (RWMA) was the same in the 2 subgroups of patients soon after reperfusion, and at follow-up it is reduced only in patients with ST reduction. Conversely, extent of contrast defect was already lower in patients with ST reduction at baseline, gradually decreasing at follow-up; therefore the extent of contrast defect is a better predictor of coronary reperfusion than wail motion abnormality. Similar results were obtained dividing our population according to coronary TIMI grade after reperfusion ( fig. 6 ). There was no difference in RWMA in TIMI 2 vs TIMI 3 patients after reperfusion. On the contrary, the extent of contrast defect after reflow was tower in TIMI 3 vs TIMI 2 group and it reduced in the course of time ( fig. 6 ). Finally, the evaluation of the extent of contrast defect may have a stron8 impact on patient manasement over the extent of RWMA. As shown in fiB. 8, the evaluation of the extent of contrast defect allows for the identification of the most effective reperfusion stratesy after acute myocardial infarction, i.e., the facilitated PCI which provides the best results in terms of coronary reperfusion. 
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